State of Alaska Department of Revenue’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

State of Alaska Department of Revenue’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,954	Closed	-$88K	–	1647
2017 Q4	$88K	Hold	4,954	–	–	﹤0.01%	1538
2017 Q3	$58K	Buy	4,954 +100	+2%	+$1.12K	﹤0.01%	1248
2017 Q2	$50K	Buy	4,854 +2,164	+80%	+$22.1K	﹤0.01%	1186
2017 Q1	$29K	Buy	+2,690	New	+$31.2K	﹤0.01%	1175

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

State of Alaska Department of Revenue's SCMP Position: Q1 2018 in Review

State of Alaska Department of Revenue sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 4,954 shares — an estimated $88K sold.

State of Alaska Department of Revenue first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $88K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

State of Alaska Department of Revenue reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
State of Alaska Department of Revenue sold 4,954 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $88K.
State of Alaska Department of Revenue first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
State of Alaska Department of Revenue's Sucampo Pharmaceuticals, Inc. position peaked at $88K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2018, filed 19 Apr 2018.